FDA Approved: PAXIL — Supplemental Application (Apotex Corp)

View source ↗

Summary

FDA approved a supplemental application for Paxil (paroxetine hydrochloride) submitted by Apotex Corp.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Major Depressive Disorder
• Obsessive-compulsive Disorder
• Panic Disorder
• Post-traumatic Stress Disorder
• Premenstrual Dysphoric Disorder
• Social Anxiety Disorder

Drugs mentioned

• PAXIL (paroxetine hydrochloride)

Snippet

SUPPL AP for PAXIL (PAROXETINE HYDROCHLORIDE)